Meeting
2022 ASCO Quality Care Symposium
Association of clinic type with receipt of neoadjuvant therapy among patients with localized pancreatic cancer: Value of multidisciplinary clinic.
Authors
Priya Pathak
Department of Radiation Oncology, Johns Hopkins School of Medicine, Baltimore, MD
Priya Pathak, Amy Hacker-Prietz, Joseph M. Herman, Lei Zheng, Jin He, Amol Narang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience
Sub Track
Team-Based Approaches to Care Delivery
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 63)
DOI
10.1200/JCO.2022.40.28_suppl.063
Abstract #
63
Poster Bd #
C3
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Uptake in genetic testing in patients with pancreatic cancer with oncologist-driven testing protocol.
First Author: Traci King
Poster
2022 ASCO Annual Meeting
Gut microbiota composition and outcomes following neoadjuvant therapy in patients with localized pancreatic cancer: A prospective biomarker study.
First Author: Pranav Murthy
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of race and CA 19-9 nonproduction with limited pathologic response to neoadjuvant chemotherapy in patients with localized pancreatic cancer.
First Author: Mary P. Martos
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Effect of neoadjuvant therapy pathway (NATP) for pancreatic cancer on overall patient outcomes.
First Author: Dylan Cooper